Precision Immunotherapy

Immunotherapy is a type of treatment that helps the body’s immune system fight cancer. Several kinds of immunotherapy, including immune checkpoint inhibitors, adoptive cell transfer, and therapeutic vaccines are either commercially available or in clinical development. To date, six immune checkpoint inhibitors have been approved by FDA for the treatment of eight types of cancer. One of the inhibitors has also been approved to treat any solid tumour that has a specific genetic feature. This was the first FDA approval of its kind and a major advance for precision cancer medicine, in which the molecular characteristics of a tumour are used to identify effective therapies.

  • adoptive cell transfer
  • clinical development
  • molecular characteristics of a tumour

Related Conference of Precision Immunotherapy

April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 21-22, 2025

24th International Conference on Genomics and Molecular Biology

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France
August 25-26, 2025

8th International Conference on Community Nursing and Public Health

Singapore City, Singapore
September 22-23, 2025

39th International Conference on Cancer Science & Therapy

Amsterdam, Netherlands
September 22-23, 2025

17th Annual Congress on Drug Formulation & Analytical Techniques

Amsterdam, Netherlands
October 16-17, 2025

19th International Conference on Pathology and Laboratory Medicine

Aix-en-Provence, France
November 03-04, 2025

5th World Medicine Congress

Rome, Italy

Precision Immunotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in